Yuanfang Z. Ma
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Establishment of a Keratin 14/17-Induced Antigen-Specific Psoriasis-like Mouse Model.
Journal: Biology
Published: May 22, 2026
Probiotic and antibacterial properties of recombinant Lactococcus lactis expressing the fusion antimicrobial peptides BMAP18-BSN37 in mice and chickens.
Journal: Poultry science
Published: September 23, 2025
Protective effect of Lactococcus lactis NZ9000 secreting Bcl2 against Trichinella spiralis infection in mice.
Journal: BMC veterinary research
Published: September 22, 2025
Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies.
Journal: International journal of molecular sciences
Published: August 23, 2025
The Dual Role of the TRAIL-DR5 Signaling Axis in Cardiovascular Disease: From Molecular Mechanisms to Targeted Therapies.
Journal: Biologics : targets & therapy
Published: May 05, 2025
Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation.
Journal: Journal of inflammation research
Published: October 26, 2024
Mitigation of ischemia/reperfusion injury via selenium nanoparticles: Suppression of STAT1 to inhibit cardiomyocyte oxidative stress and inflammation.
Journal: Biomaterials
Published: September 25, 2024
High glucose affects the cardiac function of diabetic Akita mice by inhibiting cardiac ATP synthase beta subunit.
Journal: International journal of cardiology. Cardiovascular risk and prevention
Published: July 24, 2024
Blocking the TRAIL-DR5 Pathway Reduces Cardiac Ischemia-Reperfusion Injury by Decreasing Neutrophil Infiltration and Neutrophil Extracellular Traps Formation.
Journal: Cardiovascular drugs and therapy
Published: May 28, 2024
Correction: Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation.
Journal: Cell death discovery
Published: September 06, 2023
Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation.
Journal: Cell death discovery
Published: November 03, 2022
Last Updated: 09/26/2026